Cervical Precancerous Lesions Clinical Trial
Official title:
Optimal Timing for Performing Loop Electrosurgical Excision Procedure According to Different Menstrual Phase: Which is Best?
Verified date | October 2019 |
Source | Erzincan Military Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Cervical precancerous lesions (cervical intraepithelial neoplasia) are frequently diagnosed
and treated in women of reproductive-aged [1]. Loop electrosurgical excision procedure (LEEP)
is the standard surgical treatment in CIN 2 or 3 [1]. This procedure is an inexpensive, easy
to learn and provide specimens for pathological examination with the least major surgical
morbidity [2].
Although LEEP is a safe procedure, complications such as postoperative bleeding have been
reported. These haemorrhages make patients anxious, undergo unnecessary follow-ups,
additional procedures to stop bleeding and interfere in patients daily activities. Various
interventions have been attempted to prevent and/or reduce perioperative and/or postoperative
haemorrhage after LEEP including vasopressiın, tranexamic acid, Monsel's solution, or local
hemostats (TochoSil or Tisseel), but have failed to show a definite advantage over routine
practice [2-4].
A hormonal variation during the menstrual cycle is known to affect hemostasis [5] and the
blood flow of the genital organ [6,7]. A systematic review of the literature through PubMed,
OvidSP, Google Scholar, and Scopus identified only one previous investigation of menstrual
cycle period affect blood loss during the LEEP procedure. The authors showed that women had
less perioperative bleeding during the follicular phase than during the luteal phase [8]. Two
retrospective studies have also demonstrated rhinoplasty and mammoplasty caused more bleeding
during the luteal phase and menstruation than during the follicular phase [9,10]. In
contrast, other retrospective studies have shown no relation between operative blood loss and
the menstrual cycle for hysterectomy, myomectomy, and ovarian cystectomy [11-13] To answer
this clinically relevant question, the investigators performed a randomized study comparing
perioperative and postoperative bleeding between patients underwent LEEP procedure during the
follicular or luteal phase of the menstrual cycle.
Status | Completed |
Enrollment | 75 |
Est. completion date | September 18, 2019 |
Est. primary completion date | September 18, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 21 Years to 65 Years |
Eligibility |
Inclusion Criteria: 1. Women was = 21 years old 2. Women was not pregnant 3. Women were not menstruating or menopausal status 4. Women with the normal regular menstrual cycle (defined as an interval between 21 and 35 days and duration between 3 and 10 days) 5. Women had one of the following indications for LEEP procedure 1. a histology-proven, persistent, low grade squamous intraepithelial lesions (LGSIL), 2. a histology-proven high-grade squamous intraepithelial lesions (HGSIL), 3. discrepancies between cytological reports and colposcopic impressions, 4. investigation for unsatisfactory colposcopy, 5. micro invasion or adenocarcinoma in situ on cervical punch biopsy Exclusion Criteria: - Women with cervical or vaginal infection, - Women with the abnormal menstrual cycle, - Women taking any medication (or injection) such as oral contraceptives, GnRH agonist, medroxyprogesterone acetate, or anticoagulants - Women with coagulation defect, - Women with mental incapacity, - Women with a history of neurologic deficit, - Women with previous hysterectomy with removal of the cervix, - Women with a history of cervical cancer |
Country | Name | City | State |
---|---|---|---|
Turkey | Kemal Gungorduk | Mugla |
Lead Sponsor | Collaborator |
---|---|
Erzincan Military Hospital |
Turkey,
Paraskevaidis E, Davidson EJ, Koliopoulos G, Alamanos Y, Lolis E, Martin-Hirsch P. Bleeding after loop electrosurgical excision procedure performed in either the follicular or luteal phase of the menstrual cycle: a randomized trial. Obstet Gynecol. 2002 J — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | mean early postoperative blood loss | Estimated early postoperative blood loss was calculated using the difference in hematocrit values taken after LEEP procedure and 6 hours after procedure, according to the following formula: Estimated Blood Loss = estimated blood volume X (hematocrit 1 - hematocrit 2)/hematocrit 1, where the estimated blood volume in milliliters = woman's weight in kilograms X 85 | 6 hours | |
Secondary | mean intraoperative bleeding | The volume of intraoperative blood loss was measured by weighing a gauze sponge during the procedure. Because it is important to collect the blood accurately, we used a specially designed operating gauze sponge and an electronic scale to weigh all the material (with a 1-g deviation range). The LEEP procedure was performed ensuring that all blood lost during the procedure was absorbed with gauzes. We took care to clean all the bleeding with gauze obtained during the procedure. | During the LEEP procedure | |
Secondary | the rate of late postoperative bleeding | late postoperative bleeding (defined as bleeding that occur within four weeks after the home dischard, and required hemostatic interventions such as electrocauterization, gause packing, or cervical suturing, excluding menstrual bleeding). | bleeding that occur within four weeks after the home dischard |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT00923702 -
Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India
|
Phase 4 |